NextCure Stock (NASDAQ: NXTC) stock price, news, charts, stock research, profile.
Open | $1.60 |
Close | $1.57 |
Volume / Avg. | 24.75K / 89.33K |
Day Range | 1.56 - 1.67 |
52 Wk Range | 0.98 - 2.57 |
Market Cap | $43.64M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 48 |
Short Interest | 0.32% |
Days to Cover | 1.2 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of NextCure (NASDAQ:NXTC) through any online brokerage.
Other companies in NextCure’s space includes: Kezar Life Sciences (NASDAQ:KZR), Fortress Biotech (NASDAQ:FBIO), OncoCyte (NASDAQ:OCX), CARISMA Therapeutics (NASDAQ:CARM) and Aligos Therapeutics (NASDAQ:ALGS).
There is no analysis for NextCure.
NextCure has a consensus price target of $8.25.
The stock price for NextCure (NASDAQ: NXTC) is $1.56 last updated July 25, 2024 at 9:25 AM EDT.
There are no upcoming dividends for NextCure.
NextCure’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for NextCure.
NextCure is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.